| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8721494 | Clinical Immunology | 2017 | 6 Pages |
Abstract
We demonstrate that treatment with CsA does not impair the development of GrB+ B-cells. GrB+ B-cells may have a dual role in renal transplantation as regulatory cells to maintain allospecific tolerance and as effector cells enhancing viral control.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jiqiao Zhu, Ye Zeng, Sebastian Dolff, Anja Bienholz, Monika Lindemann, Alexandra Brinkhoff, Manfred Schedlowski, Shilei Xu, Ming Sun, Hana Guberina, Julia Kirchhof, Andreas Kribben, Oliver Witzke, Benjamin Wilde,